Hypothalamic proline-rich polypeptide protects brain neurons in aluminum neurotoxicosis

被引:26
作者
Galoyan, AA
Shakhlamov, VA
Aghajanov, MI
Vahradyan, HG
机构
[1] NAS RA, H Buniatian Inst Biochem, Yerevan 375014, Armenia
[2] Russian Acad Med Sci, Inst Human Morphol, Moscow, Russia
[3] M Heratsi State Med Univ, Yerevan, Armenia
关键词
acute aluminum neurotoxicosis; hypothalamic proline-rich polypeptide; insulin-like growth factor-1; interleukines; neuronal ultrastructure; prolactin;
D O I
10.1023/B:NERE.0000026396.77459.1f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The damaging effect of aluminum ions (Al3+) on the organism is widely investigated in clinics and experiments that indicate its role as a participant in the synthesis of precursors for amyloid proteins and as a potential agent in the ethiology of Alzheimer's disease. It has been shown that Al produces neurotoxic effects. We established that AlCl3 produces degenerative changes in the ultrastructure of Hasserian neurinoma cells in vitro and in L-929 fibroblast cells. Proline-rich peptide-1 (PRP-1) isolated from neurosecretory granules of bovine neurohypophysis is a potent antineurodegenerative agent against spinal cord hemisection and crush syndrome-induced neurodegeneration of brain and spinal cord neurons. PRP-1 is one of the neurotrophic brain factors. By electron microscopic study of the rat hippocampus and other tissues, we succeeded in visualizing the epithelioprotectory effect of PRP-1, contributing as a powerful agent in removal of aluminum accumulation in different tissues in experimental aluminum neurotoxicosis.
引用
收藏
页码:1349 / 1357
页数:9
相关论文
共 23 条
[1]  
AGADJANOV MI, 2001, J NEUROCHEMISTRY ITA, V77, P19
[2]  
Aghajanov M. I., 2000, NEUROCHEMISTRY RAS N, V17, P294
[3]   DIALYSIS ENCEPHALOPATHY SYNDROME - POSSIBLE ALUMINUM INTOXICATION [J].
ALFREY, AC ;
LEGENDRE, GR ;
KAEHNY, WD .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (04) :184-188
[4]  
APRIKYAN VS, 1999, MED SCI ARMENIA, V39, P29
[5]  
Avtsin A.P., 1991, HUMAN MICROELEMENTOS
[6]  
AVTSIN AP, 1987, CLIN MED, V6, P736
[7]  
AVTSIN AP, 1986, ARCH PATHOL, V5, P1
[8]  
CHEKHONIN V, 2001, P INT C BIOCH MOL BI, P86
[9]  
CRAPPER DR, 1978, ALZHEIMERS DISEASE S, P471
[10]  
CRAPPERMCLACHLA.DR, 1981, NEUROTOXICOLOGY, V1, P3